Aug 14, 2026 09:00AM
Aug 8, 2026 12:00PM
Aug 7, 2026 09:00AM
Aug 6, 2026 07:30AM
Aug 6, 2026 07:30AM
May 29, 2026 09:00AM
May 27, 2026 08:00AM Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 14, 2026 08:00AM BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
Mar 12, 2026 08:00AM
Feb 27, 2026 09:00AM
Feb 23, 2026 08:00AM
Feb 21, 2026 10:45AM
Feb 12, 2026 08:00AM
Jan 8, 2026 08:03AM
Jan 8, 2026 08:00AM BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease
Nov 19, 2025 08:00AM
Oct 17, 2025 09:00AM
Sep 26, 2025 09:00AM
Sep 26, 2025 08:00AM
Aug 13, 2025 04:05PM
Aug 13, 2025 04:05PM
Aug 11, 2025 04:05PM BioVie completes $12 million public offering on NASDAQ
Aug 11, 2025 04:05PM
Aug 9, 2025 12:55PM
Aug 7, 2025 08:43PM
Aug 7, 2025 08:43PM
Jul 24, 2025 08:01AM
Jul 24, 2025 08:00AM
Jul 22, 2025 09:05AM BioVie names Amy Chappell and Kameel Farag to board of directors
Jul 22, 2025 08:00AM
Jul 9, 2025 08:00AM
Jun 26, 2025 08:00AM
Jun 24, 2025 04:05PM
Jun 16, 2025 06:45PM
May 16, 2025 09:00AM
May 15, 2025 08:00AM BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
May 14, 2025 07:30AM
May 7, 2025 08:00AM
May 5, 2025 08:02AM
May 5, 2025 08:00AM
Apr 25, 2025 12:45PM
Apr 16, 2025 08:00AM
Apr 8, 2025 08:56AM ALERT: Grabar Law Office Investigates Claims on Behalf of Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); Maison Solutions Inc. (NASDAQ: MSS); and Virtu Financial
Apr 7, 2025 07:31AM

328,685 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All